Evolution of HER2-Targeted Therapy in Biliary Tract Cancer
Sep 20 2024
Length: 24 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Evolution of HER2-Targeted Therapy in Biliary Tract Cancer

Listen for free

View show details

Summary
Do you know which type of biliary tract cancer (BTC) has the highest rate of HER2 aberrations?

Credit available for this activity expires: 9/20/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001632?ecd=bdc_podcast_libsyn_mscpedu

Show more Show less

Show more Show less

What listeners say about Evolution of HER2-Targeted Therapy in Biliary Tract Cancer

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon